Importantly, inhibiting miR-152 could up-regulate the expression of its target gene RICTOR to improve the viability of osteoblasts and promote osteoblast differentiation, which is expected to provide alternative strategies and research perspective for the prevention and treatment of osteoporosis. The gene discussed is RICTOR; the disease is osteoporosis.